Daniel R. Higazi
Daniel R. Higazi publishes mostly in Molecular Biology, Neurology and Cardiology and Cardiovascular Medicine, on topics such as Protein purification and stability, Monoclonal and Polyclonal Antibodies Research and Botulinum Toxin and Related Neurological Disorders.
- World rank
- #1,642,102 of 7,710,434 ranked researchers
- Rank in United Kingdom
- #124,313 of 367,258
- Works
- 30
- Citations
- 1.3k
- Citations per work
- 43.6
What does Daniel R. Higazi research?
Daniel R. Higazi's work is mostly in Medicine (33%), Biochemistry, Genetics and Molecular Biology (29%), Immunology and Microbiology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences1342.5%
- Health Sciences1033.0%
- Medicine1033.0%
- Everything else724.5%
- 1Molecular Biology29% of their works
- 2Neurology11% of their works
- 3Cardiology and Cardiovascular Medicine11% of their works
- 4Radiology, Nuclear Medicine and Imaging11% of their works
- 5Immunology8% of their works
- 6Cellular and Molecular Neuroscience6% of their works
Research topics
- Protein purification and stability
- Monoclonal and Polyclonal Antibodies Research
- Botulinum Toxin and Related Neurological Disorders
- Viral Infectious Diseases and Gene Expression in Insects
- Mass Spectrometry Techniques and Applications
- Cardiac electrophysiology and arrhythmias
- Neurological disorders and treatments
- Glycosylation and Glycoproteins Research
Which keywords describe Daniel R. Higazi's research?
The keywords of their largest research topics: Monoclonal Antibodies, Therapeutic Antibodies, Glycosylation, Antibody Engineering, Biopharmaceuticals, Fc Receptors, Neurological Disorders and Protein Aggregation.
- Glycans
- Recombinant Protein
- Mass Spectrometry
- Long-QT Syndrome
- Deep Brain Stimulation
- Neurotoxins
- Protein Aggregation
- Fc Receptors
- Antibody Engineering
- Therapeutic Antibodies
- Monoclonal Antibodies
- Glycosylation
- Biopharmaceuticals
- Neurological Disorders
- Botulinum Toxin
- Arrhythmias
- Ionization
- Mammalian Cells
- Parkinson's Disease
- Cancer
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 20 words, with their numbers
- Monoclonal Antibodies162 topics
- Therapeutic Antibodies162 topics
- Glycosylation133 topics
- Antibody Engineering81 topic
- Biopharmaceuticals81 topic
- Fc Receptors81 topic
- Neurological Disorders82 topics
- Protein Aggregation81 topic
- Botulinum Toxin51 topic
- Neurotoxins51 topic
- Arrhythmias31 topic
- Deep Brain Stimulation31 topic
- Ionization31 topic
- Long-QT Syndrome31 topic
- Mammalian Cells31 topic
- Mass Spectrometry31 topic
- Parkinson's Disease31 topic
- Recombinant Protein31 topic
- Cancer21 topic
- Glycans21 topic
Where does Daniel R. Higazi work?
Daniel R. Higazi's main affiliation in the publication record is University of Cambridge, United Kingdom.
How many publications and citations does Daniel R. Higazi have?
OpenAlex counts 30 works and 1,307 citations for Daniel R. Higazi, an h-index of 14, ranking #1,642,102 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Daniel R. Higazi. Posts are plain text and can be reported.